(Reuters) — Law firm Kessler Topaz Meltzer & Check LLP said Sunday it has filed a securities class-action lawsuit against pharmaceutical company Natera Inc. on behalf of shareholders.
The law firm said the main justification for the lawsuit filed in the U.S. district court of the Western District of Texas was that Natera, which specializes in genetic testing and diagnostics, provided information about the efficacy of its tests that has not proved accurate.
“Natera said that its tests are much more reliable than it appears they really are,” Kessler Topaz said in a statement.
Natera, based in Austin, Texas, did not return a request for comment.
